DK1812046T3 - Melanocortinreceptor-bindende mimetilegemer, sammensætninger, fremgangsmåder og anvendelser - Google Patents

Melanocortinreceptor-bindende mimetilegemer, sammensætninger, fremgangsmåder og anvendelser

Info

Publication number
DK1812046T3
DK1812046T3 DK05819741.9T DK05819741T DK1812046T3 DK 1812046 T3 DK1812046 T3 DK 1812046T3 DK 05819741 T DK05819741 T DK 05819741T DK 1812046 T3 DK1812046 T3 DK 1812046T3
Authority
DK
Denmark
Prior art keywords
methods
receptor binding
bodies
compositions
applications
Prior art date
Application number
DK05819741.9T
Other languages
Danish (da)
English (en)
Inventor
Mark Cunningham
Vedrana Stojanovic-Susulic
Karyn O'neil
Chichi Huang
Jeffrey Luo
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Application granted granted Critical
Publication of DK1812046T3 publication Critical patent/DK1812046T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1796—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK05819741.9T 2004-10-25 2005-10-25 Melanocortinreceptor-bindende mimetilegemer, sammensætninger, fremgangsmåder og anvendelser DK1812046T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62196004P 2004-10-25 2004-10-25
PCT/US2005/038431 WO2006047535A2 (en) 2004-10-25 2005-10-25 Melanocortin receptor binding mimetibodies, compositions, methods and uses

Publications (1)

Publication Number Publication Date
DK1812046T3 true DK1812046T3 (da) 2011-06-06

Family

ID=36228385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05819741.9T DK1812046T3 (da) 2004-10-25 2005-10-25 Melanocortinreceptor-bindende mimetilegemer, sammensætninger, fremgangsmåder og anvendelser

Country Status (28)

Country Link
US (1) US20060105951A1 (https=)
EP (1) EP1812046B1 (https=)
JP (1) JP2008517605A (https=)
KR (1) KR101255140B1 (https=)
CN (1) CN101437540B (https=)
AT (1) ATE501731T1 (https=)
AU (1) AU2005299440B2 (https=)
BR (1) BRPI0518411A2 (https=)
CA (1) CA2585287A1 (https=)
CY (1) CY1111486T1 (https=)
DE (1) DE602005026970D1 (https=)
DK (1) DK1812046T3 (https=)
EA (1) EA200700944A1 (https=)
EC (1) ECSP077416A (https=)
ES (1) ES2363023T3 (https=)
HR (1) HRP20110405T1 (https=)
IL (1) IL182683A0 (https=)
MA (1) MA28943B1 (https=)
ME (1) ME01234B (https=)
MX (1) MX2007004974A (https=)
NO (1) NO20072499L (https=)
PL (1) PL1812046T3 (https=)
PT (1) PT1812046E (https=)
RS (1) RS51789B (https=)
SI (1) SI1812046T1 (https=)
TN (1) TNSN07157A1 (https=)
WO (1) WO2006047535A2 (https=)
ZA (1) ZA200704260B (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
WO2009151383A1 (en) * 2008-06-09 2009-12-17 Palatin Technologies, Inc. Melanocortin receptor-specific peptides for the treatment of obesity and other diseases associated with melanocortin receptor function
KR101687037B1 (ko) 2008-06-09 2016-12-15 팔라틴 테크놀로지스 인코포레이티드 성기능 장애 치료용 멜라노코르틴 수용체-특이적 펩티드
US8614185B2 (en) * 2009-05-04 2013-12-24 Centocor Ortho Biotech Inc. Fusion proteins of alpha-MSH derivatives and Fc
EP2440572B1 (en) 2009-06-08 2017-04-05 Palatin Technologies, Inc. Lactam-bridged melanocortin receptor-specific peptides
UY32690A (es) 2009-06-08 2011-01-31 Astrazeneca Ab Péptidos específicos para receptores de melanocortina
CA2761607C (en) 2009-06-08 2018-09-04 Yi-Qun Shi Melanocortin receptor-specific peptides
BR112012011780A2 (pt) 2009-11-23 2019-09-24 Palatin Technologies, Inc peptídeo linear,composição farmacêutica,métodopara tratamento de umadoença,indicação,condição ou sídrome mediadsa por receptor de melanocortina emum mamífero humano ou não humano e método para tratamento de uma condição responsiva ás alterações em função de receptor de melanocortina em um mamifero humano ou não humano
JP5999702B2 (ja) 2009-11-23 2016-09-28 パラティン テクノロジーズ, インコーポレイテッドPalatin Technologies, Inc. メラノコルチン−１受容体特異的環状ペプチド
JP2020141710A (ja) * 2011-07-06 2020-09-10 ゲンマブ エー／エス 抗体重鎖のｃ末端の修飾による補体依存性細胞傷害の調節
WO2020177627A1 (zh) * 2019-03-02 2020-09-10 上海一宸医药科技有限公司 一种双特异抗体

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1137340A4 (en) * 1998-12-09 2005-12-21 Eleanor Roosevelt Inst COMPOSITION AND METHODS FOR REGULATION OF BODY WEIGHT AND ASSOCIATED PATHOLOGIES
AU7593001A (en) * 2000-07-14 2002-01-30 Zycos Inc Alpha-msh related compounds and methods of use
CA2490409A1 (en) * 2002-06-28 2004-01-08 Centocor, Inc. Mammalian ch1 deleted mimetibodies, compositions, methods and uses
US7241733B2 (en) * 2002-06-28 2007-07-10 Centocor, Inc. Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
US20070135338A1 (en) * 2004-03-31 2007-06-14 Karyn O'neil Human GLP-1 mimetibodies, compositions, methods and uses

Also Published As

Publication number Publication date
AU2005299440A1 (en) 2006-05-04
US20060105951A1 (en) 2006-05-18
EP1812046A4 (en) 2009-11-11
ME01234B (me) 2013-06-20
EP1812046B1 (en) 2011-03-16
ATE501731T1 (de) 2011-04-15
EP1812046A2 (en) 2007-08-01
HK1106445A1 (en) 2008-03-14
RS51789B (sr) 2011-12-31
MX2007004974A (es) 2007-10-17
DE602005026970D1 (de) 2011-04-28
MA28943B1 (fr) 2007-10-01
ZA200704260B (en) 2009-03-25
ES2363023T3 (es) 2011-07-19
IL182683A0 (en) 2007-09-20
CA2585287A1 (en) 2006-05-04
PT1812046E (pt) 2011-06-28
HRP20110405T1 (hr) 2011-06-30
KR20070085416A (ko) 2007-08-27
ECSP077416A (es) 2007-05-30
WO2006047535A2 (en) 2006-05-04
CN101437540A (zh) 2009-05-20
AU2005299440B2 (en) 2011-12-15
PL1812046T3 (pl) 2011-08-31
KR101255140B1 (ko) 2013-04-22
EA200700944A1 (ru) 2008-04-28
BRPI0518411A2 (pt) 2008-11-18
WO2006047535A3 (en) 2008-09-04
JP2008517605A (ja) 2008-05-29
CY1111486T1 (el) 2015-08-05
TNSN07157A1 (en) 2008-11-21
NO20072499L (no) 2007-07-16
SI1812046T1 (sl) 2011-06-30
CN101437540B (zh) 2012-12-19

Similar Documents

Publication Publication Date Title
NO20072499L (no) Melanocortinreseptorbindende mimetistoffer, sammensetninger, fremgangsmater og anvendelser
DK1864132T3 (da) Fra amnion stammende cellesammensætninger, fremgangsmåder til fremstilling deraf og anvendelser deraf
WO2007041635A3 (en) Fc variants with optimized fc receptor binding properties
TW200611910A (en) Interferon-alpha polypeptides and conjugates
DK2390267T3 (da) Stabile og opløselige antistoffer, der hæmmer TNF(alfa)
WO2006083276A3 (en) Interferon-alpha polypeptides and conjugates
DK2574640T3 (da) Bindemidler og dermed fremstillede materialer
DK1919514T3 (da) Polynucleotider kodende for isoprenoid-modificerende enzymer og fremgangsmåder til anvendelse deraf
WO2006017538A3 (en) Hk1-binding proteins
DK3219328T3 (da) Humane anti-il-23-antistoffer, sammensætninger, fremgangsmåder og anvendelser
GB2430677A8 (en) Novel antigenbinding polypeptides and their uses
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
WO2006055689A3 (en) Protein scaffolds and uses thereof
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
DK1871805T3 (da) Antigenbindende molekyler der binder egfr, vektorer der koder derfor, og anvendelser deraf
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
TW200720076A (en) Composite materials and methods of making the same
WO2007104062A8 (en) Compositions and methods based on peptide binding profiling
NO20055686L (no) Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav.
WO2007079218A3 (en) Metalloproteinase binding proteins
NO20091181L (no) Anti-C5AR-antistoffer med forbedrede egenskaper
WO2008154547A3 (en) Spider silk dragline polynucleotides, polypeptides and methods of use thereof
WO2008086035A3 (en) Split mutant hydrolase fusion reporter and uses thereof
TW200745159A (en) IL-6 binding proteins
WO2007044083A3 (en) Evolved interferon-alpha polypeptides